Literature DB >> 22472779

Adherence to therapeutic and diagnostic recommendations in patients with femur fracture and at risk of re-fracture or death: results of an analysis of administrative databases.

L Degli Esposti1, L Sinigaglia, M Rossini, S Adami, C Cagnoni, C Magliaro, C Veronesi, S Buda, S Minisola.   

Abstract

The aim of the present study was to evaluate the application into clinical practice of therapeutic and diagnostic recommendations for the prevention of bone re-fracture in postmenopausal women after an hospitalization for hip fracture in clinical practice and to assess the relationship between the application of diagnostic recommendations and re-fracture or death risk. A retrospective cohort analysis was conducted. All female patients, at least 65 years old, and with an hospitalization with main or secondary diagnosis of hip fracture during the period 1 January 2006 - 31 December 2008, were included. Besides demographic characteristics and comorbidities, drug treatment prescriptions related to bone fracture or supplementary with calcium or vitamin D and prescriptions of recommended laboratory and instrumental diagnostic tests (e.g. spine radiography), were analysed. A total of 5,636 patients were included in the study. The prescription of a drug treatment aimed to reduce the risk of re-fracture was found in 16.3% of patients, among them 76.3% (699 patients) used bisphosphonates only, 17.1% (157 patients) strontium ranelate only and 4.9% (45 patients) used more than one treatment during the observation period. Among the patients who did not receive drug treatment, 17.5% made use of only supplemental calcium and vitamin D. The remaining part of patients (69.1%) received no treatment. The prescription of at least one laboratory test of first and second level was performed, respectively, on 53.7% and 43.1% of included patients, whereas the prescription of at least one instrumental test of first and second level was performed, respectively, on 5.9% and 0.8%. Although it is established that the prescription of the recommended tests and appropriate drug treatment are significantly associated with reduced risk of re-fracture and death, today the application of these recommendations is reduced.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22472779     DOI: 10.4081/reumatismo.2012.18

Source DB:  PubMed          Journal:  Reumatismo        ISSN: 0048-7449


  3 in total

1.  The T.A.R.Ge.T. project: a regional program to reduce hip fracture in elderly patients. Main results of retrospective phase.

Authors:  Simone Parri; Luisella Cianferotti; Gemma Marcucci; Giorgio Gronchi; Carla Rizzuti; Emanuela Colli; Beatrice Manetti; Walter Naldoni; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2015 Jan-Apr

2.  Evaluation of a topical herbal agent for the promotion of bone healing.

Authors:  Wing-Sum Siu; Chun-Hay Ko; Ka-Wing Lam; Elaine Wat; Wai-Ting Shum; Clara Bik-San Lau; Kam-Ming Ko; Leung-Kim Hung; David Tai-Wai Lau; Ping-Chung Leung
Journal:  Evid Based Complement Alternat Med       Date:  2015-02-25       Impact factor: 2.629

Review 3.  Adherence to Anti-Osteoporotic Treatment and Clinical Implications after Hip Fracture: A Systematic Review.

Authors:  Ramona Dobre; Dan Alexandru Niculescu; Răzvan-Cosmin Petca; Răzvan-Ionuț Popescu; Aida Petca; Cătălina Poiană
Journal:  J Pers Med       Date:  2021-04-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.